NextCure Inc
PublicNextCure Inc is now publicly traded
The data on this page reflects NextCure Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Mar 5, 2026
Total Funding Raised
$40.5M
Company Overview
NextCure Inc operates in Healthcare and is based in the United States. It has raised $40.5M.
NextCure Inc is a biotechnology company that discovers and develops novel immunomedicines to treat cancer and other immune-related diseases.
Sector
Healthcare
AI Layer
Non-AI
NextCure Inc Comparables
Compare NextCure Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OnCusp Therapeutics | 82% | |
| Immunitas Therapeutics | 76% | |
| Dren Bio | 75% |
For institutional investors. Book with your work email.
NextCure Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2026 | ||||
| PIPE | Nov 17, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NextCure Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Ikarian Capital | PIPE |
| Canaan Partners | Series A |
| Exome Asset Management | PIPE |
| Oncology Ventures | Series A |
| Squadron Capital Management LLC | PIPE |
| Cencora Ventures | Series A |
NextCure Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.